157 related articles for article (PubMed ID: 31309086)
1. Role of redox iron towards an increase in mortality among patients: a systemic review and meta-analysis.
Sharma S
Blood Res; 2019 Jun; 54(2):87-101. PubMed ID: 31309086
[TBL] [Abstract][Full Text] [Related]
2. Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.
Porter JB; Cappellini MD; Kattamis A; Viprakasit V; Musallam KM; Zhu Z; Taher AT
Br J Haematol; 2017 Jan; 176(2):288-299. PubMed ID: 27917462
[TBL] [Abstract][Full Text] [Related]
3. Non-transferrin bound iron in Thalassemia: differential detection of redox active forms in children and older patients.
Breuer W; Ghoti H; Shattat A; Goldfarb A; Koren A; Levin C; Rachmilewitz E; Cabantchik ZI
Am J Hematol; 2012 Jan; 87(1):55-61. PubMed ID: 22125177
[TBL] [Abstract][Full Text] [Related]
4. Residual erythropoiesis protects against myocardial hemosiderosis in transfusion-dependent thalassemia by lowering labile plasma iron via transient generation of apotransferrin.
Garbowski MW; Evans P; Vlachodimitropoulou E; Hider R; Porter JB
Haematologica; 2017 Oct; 102(10):1640-1649. PubMed ID: 28642302
[TBL] [Abstract][Full Text] [Related]
5. Iron and oxidative stress in cardiomyopathy in thalassemia.
Berdoukas V; Coates TD; Cabantchik ZI
Free Radic Biol Med; 2015 Nov; 88(Pt A):3-9. PubMed ID: 26216855
[TBL] [Abstract][Full Text] [Related]
6. Non-transferrin bound iron, cytokine activation and intracellular reactive oxygen species generation in hemodialysis patients receiving intravenous iron dextran or iron sucrose.
Pai AB; Conner T; McQuade CR; Olp J; Hicks P
Biometals; 2011 Aug; 24(4):603-13. PubMed ID: 21229380
[TBL] [Abstract][Full Text] [Related]
7. Serum non-transferrin-bound iron in beta-thalassaemia major patients treated with desferrioxamine and L1.
al-Refaie FN; Wickens DG; Wonke B; Kontoghiorghes GJ; Hoffbrand AV
Br J Haematol; 1992 Oct; 82(2):431-6. PubMed ID: 1419825
[TBL] [Abstract][Full Text] [Related]
8. Iron metabolism in hemodialyzed patients - a story half told?
Malyszko J; Koc-Zorawska E; Levin-Iaina N; Slotki I; Matuszkiewicz-Rowinska J; Glowinska I; Malyszko JS
Arch Med Sci; 2014 Dec; 10(6):1117-22. PubMed ID: 25624847
[TBL] [Abstract][Full Text] [Related]
9. Does non-transferrin bound iron contribute to transfusion related immune-modulation in preterms?
Stark MJ; Keir AK; Andersen CC
Arch Dis Child Fetal Neonatal Ed; 2013 Sep; 98(5):F424-9. PubMed ID: 23475935
[TBL] [Abstract][Full Text] [Related]
10. Non-transferrin bound iron: a key role in iron overload and iron toxicity.
Brissot P; Ropert M; Le Lan C; Loréal O
Biochim Biophys Acta; 2012 Mar; 1820(3):403-10. PubMed ID: 21855608
[TBL] [Abstract][Full Text] [Related]
11. Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes.
de Swart L; Reiniers C; Bagguley T; van Marrewijk C; Bowen D; Hellström-Lindberg E; Tatic A; Symeonidis A; Huls G; Cermak J; van de Loosdrecht AA; Garelius H; Culligan D; Macheta M; Spanoudakis M; Panagiotidis P; Krejci M; Blijlevens N; Langemeijer S; Droste J; Swinkels DW; Smith A; de Witte T;
Haematologica; 2018 Jan; 103(1):69-79. PubMed ID: 29122992
[TBL] [Abstract][Full Text] [Related]
12. Erythrocytes, leukocytes and platelets as a source of oxidative stress in chronic vascular diseases: detoxifying mechanisms and potential therapeutic options.
Martin-Ventura JL; Madrigal-Matute J; Martinez-Pinna R; Ramos-Mozo P; Blanco-Colio LM; Moreno JA; Tarin C; Burillo E; Fernandez-Garcia CE; Egido J; Meilhac O; Michel JB
Thromb Haemost; 2012 Sep; 108(3):435-42. PubMed ID: 22836558
[TBL] [Abstract][Full Text] [Related]
13. Labile plasma iron as an indicator of patient adherence to iron chelation treatment.
Steinberg-Shemer O; Yacobovich J; Cohen M; Cabantchik IZ; Tamary H
Blood Cells Mol Dis; 2018 Jul; 71():1-4. PubMed ID: 29395830
[TBL] [Abstract][Full Text] [Related]
14. Liver iron concentrations and urinary hepcidin in beta-thalassemia.
Origa R; Galanello R; Ganz T; Giagu N; Maccioni L; Faa G; Nemeth E
Haematologica; 2007 May; 92(5):583-8. PubMed ID: 17488680
[TBL] [Abstract][Full Text] [Related]
15. The antioxidant effect of fermented papaya preparation involves iron chelation.
Prus E; Fibach E
J Biol Regul Homeost Agents; 2012; 26(2):203-10. PubMed ID: 22824747
[TBL] [Abstract][Full Text] [Related]
16. [Non-transferrin-bound iron: a promising biomarker in iron overload disorders].
Maas RP; Voets PJ; de Swart L; Swinkels DW
Ned Tijdschr Geneeskd; 2013; 157(49):A6258. PubMed ID: 24299624
[TBL] [Abstract][Full Text] [Related]
17. Bleomycin-detectable iron assay for non-transferrin-bound iron in hematologic malignancies.
von Bonsdorff L; Lindeberg E; Sahlstedt L; Lehto J; Parkkinen J
Clin Chem; 2002 Feb; 48(2):307-14. PubMed ID: 11805012
[TBL] [Abstract][Full Text] [Related]
18. Non-transferrin-bound iron during blood transfusion cycles in beta-thalassemia major.
Grosse R; Lund U; Caruso V; Fischer R; Janka GE; Magnano C; Engelhardt R; Dürken M; Nielsen P
Ann N Y Acad Sci; 2005; 1054():429-32. PubMed ID: 16339692
[TBL] [Abstract][Full Text] [Related]
19. Oxidative status and malondialdehyde in beta-thalassaemia patients.
Cighetti G; Duca L; Bortone L; Sala S; Nava I; Fiorelli G; Cappellini MD
Eur J Clin Invest; 2002 Mar; 32 Suppl 1():55-60. PubMed ID: 11886433
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence assay of non-transferrin-bound iron in thalassemic sera using bacterial siderophore.
Sharma M; Saxena R; Gohil NK
Anal Biochem; 2009 Nov; 394(2):186-91. PubMed ID: 19632191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
